Contraception Selection, Effectiveness, and Adverse Effects: A Review.
Teal S, Edelman A.
JAMA. 2021 Dec 28;326(24):2507-2518. doi: 10.1001/jama.2021.21392.
Subdermal progestin implant contraception.
Darney PD.
Curr Opin Obstet Gynecol. 1991 Aug;3(4):470-6.
Norplant: subdermal implant system for long-term contraception.
Shoupe D, Mishell DR.
Am J Obstet Gynecol. 1989 May;160(5 Pt 2):1286-92. doi: 10.1016/s0002-9378(89)80014-6.
Long-acting reversible contraceptive (LARCs) methods.
Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV.
Best Pract Res Clin Obstet Gynaecol. 2020 Jul;66:28-40. doi: 10.1016/j.bpobgyn.2019.12.002. Epub 2019 Dec 20.
A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
Moray KV, Chaurasia H, Sachin O, Joshi B.
Reprod Health. 2021 Jan 6;18(1):4. doi: 10.1186/s12978-020-01054-y.
Difficult implant removals.
Voedisch A, Hugin M.
Curr Opin Obstet Gynecol. 2017 Dec;29(6):449-457. doi: 10.1097/GCO.0000000000000416.
Subdermal contraceptive implants.
Bahamondes L, Bahamondes MV, Juliato CRT.
Best Pract Res Clin Obstet Gynaecol. 2025 Jun;100:102604. doi: 10.1016/j.bpobgyn.2025.102604. Epub 2025 Mar 22.
Hormonal contraception.
Baird DT, Glasier AF.
N Engl J Med. 1993 May 27;328(21):1543-9. doi: 10.1056/NEJM199305273282108.
One-year incidence of low libido in women using levonorgestrel subdermal implant as contraception. Cohort study. Armenia, Colombia, 2014-2019.
Espitia De La Hoz FJ.
Rev Colomb Obstet Ginecol. 2021 Mar 30;72(1):33-42. doi: 10.18597/rcog.3520.
The role of progestin subdermal implant in the management of adenomyosis: a systematic review.
Chene G, Baffet H, Cerruto E, Nohuz E, Agostini A.
Eur J Contracept Reprod Health Care. 2024 Apr;29(2):61-68. doi: 10.1080/13625187.2024.2314298. Epub 2024 Mar 1.
